title: Polymorphism of Pro12Ala in the peroxisome proliferator-activated receptor gamma2 gene in Iranian diabetic and obese subjects.
abstract: BACKGROUND
  Peroxisome proliferator-activated receptor gamma2 (PPARgamma2) is a nuclear receptor that regulates adipocyte differentiation, lipid metabolism, and insulin sensitivity. The aim of this study was to investigate the association between the Pro12Ala single nucleotide polymorphism (SNP) at the PPARgamma2 gene and type II diabetes (T2DM) and obesity in an Iranian population.
  
  
  METHODS
  The genomic DNA of the 312 subjects included four groups: (1) nonobese with type II diabetes, (2) obese without type II diabetes, (3) obese with type II diabetes, and (4) nondiabetic nonobese controls. The Pro12Ala polymorphism was detected by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis.
  
  
  RESULTS
  Frequencies of the Ala allele in obese subjects were significantly different from those control subjects (odds ratio [OR], 2.358; 95% confidence interval [CI], 1.101-5.05) (P = 0.025). In contrast, no significant association was detected between the Pro12Ala polymorphism and type II diabetes (OR, 0.652; 95% CI, 0.261-1.628). In all subjects, the Ala carriers had a higher body mass index (BMI) compared with the common allele.
  
  
  CONCLUSIONS
  Our results showed that the Pro12Ala polymorphism in the PPARgamma2 gene is associated with obesity in Iranian subjects and the presence of the Ala allele could predict higher BMI.
authors: Department of Hygiene, Golestan University of Medical Sciences, Gorgan, Iran. swt_f@yahoo.com
authors: Hassan
authors: H
authors: Mirzaei
authors: Seyed Mohammad
authors: SM
authors: Akrami
authors: Taghi
authors: T
authors: Golmohammadi
authors: Mahmood
authors: M
authors: Doosti
authors: Ramin
authors: R
authors: Heshmat
authors: Manouchehr
authors: M
authors: Nakhjavani
authors: Parvin
authors: P
authors: Amiri
mesh_terms: D000409:Alanine; D044466:Asian People / Q000235:genetics*; D015992:Body Mass Index; D016022:Case-Control Studies; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000208:ethnology / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006801:Humans; D007492:Iran / Q000453:epidemiology; D016015:Logistic Models; D008297:Male; D009765:Obesity / Q000208:ethnology / Q000235:genetics* / Q000503:physiopathology; D016017:Odds Ratio; D047495:PPAR gamma / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide; D011392:Proline; D018570:Risk Assessment; D012307:Risk Factors
chemical_list: D047495:PPAR gamma; D011392:Proline; D000409:Alanine